Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6400 | 1490 | 29.4 | 48% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
6400 | 1 | DOXAZOSIN//AJ 2615//CAS 103377 41 9 | 1490 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DOXAZOSIN | authKW | 204818 | 4% | 17% | 60 |
2 | AJ 2615 | authKW | 138315 | 1% | 75% | 9 |
3 | CAS 103377 41 9 | authKW | 102459 | 0% | 100% | 5 |
4 | MONATEPIL MALEATE | authKW | 85381 | 0% | 83% | 5 |
5 | CAS 52712 76 2 | authKW | 61476 | 0% | 100% | 3 |
6 | DOXAZOSIN GITS | authKW | 61470 | 0% | 50% | 6 |
7 | BUNAZOSIN | authKW | 46093 | 1% | 25% | 9 |
8 | CAS 74191 85 8 | authKW | 40984 | 0% | 100% | 2 |
9 | AMLODIPINE THERAPY | authKW | 27321 | 0% | 67% | 2 |
10 | GASTROINTESTINAL THERAPEUTIC SYSTEM GITS | authKW | 27321 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 6244 | 26% | 0% | 388 |
2 | Pharmacology & Pharmacy | 6210 | 38% | 0% | 572 |
3 | Medicine, General & Internal | 3924 | 24% | 0% | 365 |
4 | Peripheral Vascular Diseases | 2210 | 12% | 0% | 177 |
5 | Medicine, Research & Experimental | 664 | 9% | 0% | 133 |
6 | Toxicology | 50 | 3% | 0% | 38 |
7 | Primary Health Care | 14 | 0% | 0% | 6 |
8 | Urology & Nephrology | 14 | 2% | 0% | 25 |
9 | Endocrinology & Metabolism | 11 | 2% | 0% | 36 |
10 | Physiology | 3 | 2% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS STUDY | 20492 | 0% | 100% | 1 |
2 | CLIN PHYSIOL HYPERTENS MED CLIN | 20492 | 0% | 100% | 1 |
3 | D CAMPANACCI CLIN MED PL BIOTECHNOL C DE | 20492 | 0% | 100% | 1 |
4 | DIPARTIMENTO MED CLIN SPERIMENTALE CLIN MED 4 | 20492 | 0% | 100% | 1 |
5 | DR HESHMAT CARDIOVASC | 20492 | 0% | 100% | 1 |
6 | ENDOCRINOL SECTLIPIDS | 20492 | 0% | 100% | 1 |
7 | HOSP SAN CECILIO GRANADA | 20492 | 0% | 100% | 1 |
8 | INVEST PREVENT MED PUBL HLTH | 20492 | 0% | 100% | 1 |
9 | NEPHROL SECTEXPT HYPERTENS | 20492 | 0% | 100% | 1 |
10 | PHYS SCI NUTR SCI | 20492 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 26645 | 5% | 2% | 79 |
2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 25886 | 8% | 1% | 118 |
3 | AMERICAN JOURNAL OF MEDICINE | 17908 | 7% | 1% | 99 |
4 | AMERICAN HEART JOURNAL | 12849 | 6% | 1% | 95 |
5 | ACTA MEDICA SCANDINAVICA | 10700 | 2% | 2% | 33 |
6 | JOURNAL OF HUMAN HYPERTENSION | 4663 | 2% | 1% | 29 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 4581 | 3% | 1% | 40 |
8 | DRUG INVESTIGATION | 4491 | 1% | 3% | 8 |
9 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 4188 | 3% | 1% | 41 |
10 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 3794 | 2% | 1% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOXAZOSIN | 204818 | 4% | 17% | 60 | Search DOXAZOSIN | Search DOXAZOSIN |
2 | AJ 2615 | 138315 | 1% | 75% | 9 | Search AJ+2615 | Search AJ+2615 |
3 | CAS 103377 41 9 | 102459 | 0% | 100% | 5 | Search CAS+103377+41+9 | Search CAS+103377+41+9 |
4 | MONATEPIL MALEATE | 85381 | 0% | 83% | 5 | Search MONATEPIL+MALEATE | Search MONATEPIL+MALEATE |
5 | CAS 52712 76 2 | 61476 | 0% | 100% | 3 | Search CAS+52712+76+2 | Search CAS+52712+76+2 |
6 | DOXAZOSIN GITS | 61470 | 0% | 50% | 6 | Search DOXAZOSIN+GITS | Search DOXAZOSIN+GITS |
7 | BUNAZOSIN | 46093 | 1% | 25% | 9 | Search BUNAZOSIN | Search BUNAZOSIN |
8 | CAS 74191 85 8 | 40984 | 0% | 100% | 2 | Search CAS+74191+85+8 | Search CAS+74191+85+8 |
9 | AMLODIPINE THERAPY | 27321 | 0% | 67% | 2 | Search AMLODIPINE+THERAPY | Search AMLODIPINE+THERAPY |
10 | GASTROINTESTINAL THERAPEUTIC SYSTEM GITS | 27321 | 0% | 67% | 2 | Search GASTROINTESTINAL+THERAPEUTIC+SYSTEM+GITS | Search GASTROINTESTINAL+THERAPEUTIC+SYSTEM+GITS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FULTON, B , WAGSTAFF, AJ , SORKIN, EM , (1995) DOXAZOSIN - AN UPDATE OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS IN HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA.DRUGS. VOL. 49. ISSUE 2. P. 295-320 | 82 | 79% | 137 |
2 | JOHNSON, BF , DANYLCHUK, MA , (1989) THE RELEVANCE OF PLASMA-LIPID CHANGES WITH CARDIOVASCULAR DRUG-THERAPY.MEDICAL CLINICS OF NORTH AMERICA. VOL. 73. ISSUE 2. P. 449-473 | 93 | 86% | 21 |
3 | LARDINOIS, CK , NEUMAN, SL , (1988) THE EFFECTS OF ANTIHYPERTENSIVE AGENTS ON SERUM-LIPIDS AND LIPOPROTEINS.ARCHIVES OF INTERNAL MEDICINE. VOL. 148. ISSUE 6. P. 1280 -1288 | 90 | 75% | 158 |
4 | OSCHEPKOVA, EV , EPIFANOVA, ON , ARABIDZE, GG , (1998) THE USE OF ALPHA-ADRENOBLOCKER DOXAZOSIN IN THE TREATMENT OF HYPERTENSION.KARDIOLOGIYA. VOL. 38. ISSUE 4. P. 76 -82 | 62 | 84% | 0 |
5 | WEIDMANN, P , FERRIER, C , SAXENHOFER, H , UEHLINGER, DE , TROST, BN , (1988) SERUM-LIPOPROTEINS DURING TREATMENT WITH ANTIHYPERTENSIVE DRUGS.DRUGS. VOL. 35. ISSUE . P. 118-134 | 59 | 81% | 61 |
6 | MADU, EC , REDDY, RC , MADU, AN , ANYAOGU, C , HARRIS, T , FRAKER, TD , (1996) THE EFFECTS OF ANTIHYPERTENSIVE AGENTS ON SERUM LIPIDS.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 312. ISSUE 2. P. 76-84 | 55 | 62% | 6 |
7 | HOUSTON, MC , (1989) NEW INSIGHTS AND NEW APPROACHES FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - SELECTION OF THERAPY BASED ON CORONARY HEART-DISEASE RISK FACTOR-ANALYSIS, HEMODYNAMIC PROFILES, QUALITY OF LIFE, AND SUBSETS OF HYPERTENSION.AMERICAN HEART JOURNAL. VOL. 117. ISSUE 4. P. 911-951 | 94 | 43% | 84 |
8 | WEIDMANN, P , UEHLINGER, DE , GERBER, A , (1985) ANTIHYPERTENSIVE TREATMENT AND SERUM-LIPOPROTEINS.JOURNAL OF HYPERTENSION. VOL. 3. ISSUE 4. P. 297-306 | 50 | 88% | 171 |
9 | HERAN, BS , GALM, BP , WRIGHT, JM , (2012) BLOOD PRESSURE LOWERING EFFICACY OF ALPHA BLOCKERS FOR PRIMARY HYPERTENSION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 8. P. - | 29 | 69% | 6 |
10 | POOL, JL , (1991) EFFECTS OF DOXAZOSIN ON SERUM-LIPIDS - A REVIEW OF THE CLINICAL-DATA AND MOLECULAR-BASIS FOR ALTERED LIPID-METABOLISM.AMERICAN HEART JOURNAL. VOL. 121. ISSUE 1. P. 251-260 | 42 | 88% | 41 |
Classes with closest relation at Level 1 |